Leveraging Antisense Technology in the Lungs: RNA-Targeting Therapies for Respiratory Diseases1 1 The full text of this article was published in BioDrugs 2006; 20 (1): 1-11. The original article was written by Marina Ulanova and Dean Befus from the University of Alberta, Edmonton, AB, Canada, and Alan Schreiber from the University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Author: Adis International Limited  

Publisher: Adis International

ISSN: 1176-3469

Source: Pharmaceutical & Diagnostic Innovation, Vol.4, Iss.3, 2006-01, pp. : 3-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content